New Italian study below [1].
I posted a review of PCa-coffee research 10 months ago:
"Foods/Supplements-Vitamins: Coffee"
There seems to be no doubt, from studies published in the past 7 years, that coffee drinkers obtain some protection. & so I find the opening to the new study to be odd:
"Meta-analytic data on the effect of coffee in prostate cancer risk are controversial."
{From the latest meta-analysis (2016) [2]:
"105 individual prospective studies were included. Inverse associations were observed on oral, pharyngeal, colon, liver, prostate, endometrial cancer and melanoma". But not for lung cancer.}
Also odd, is the focus on caffeine, which has been ruled out as having a major role, since decaf drinkers also receive protection.
Anyway, regarding "Italian-style coffee":
"newly diagnosed prostate cancer participants presented lower coffee consumption (60.1 ± 51.3 g/day) compared to the disease-free population (74.0 ± 51.7 g/day) "
"Multiadjusted analysis showed that the subjects at highest consumption (>3 cups/day) had 53% lower prostate cancer risk as compared to participants at the lowest consumption (0-2 cups/day)".
The study also found that:
"human prostate cancer cell lines treated with caffeine showed a significant reduction in their proliferative and metastatic behaviors"
but, whatever effect caffeine might have, it seems a basic mistake in the human study to have not distinguished between decaf & regular drinkers.
"Italian-style coffee" is mentioned 3 times. Could that exclude decaf perhaps?
Or do they simply mean "espresso", which, like Swedish boiled coffee, preserves the volatile oils removed by paper filters.
Regardless, it's yet another positive finding for coffee.
...
Of more interest is how coffee might affect survival. This is from my old post:
[3] (2011 - U.S.) "47,911 men in the Health Professionals Follow-up Study who reported intake of regular and decaffeinated coffee in 1986 and every 4 years thereafter. From 1986 to 2006, 5035 patients with prostate cancer were identified, including 642 patients with lethal prostate cancers, defined as fatal or metastatic."
"Men who consumed six or more cups per day had a lower adjusted relative risk for overall prostate cancer compared with nondrinkers (RR = 0.82 ...)"
"The association was stronger for lethal prostate cancer (consumers of more than six cups of coffee per day: RR = 0.40 ..."
"The inverse association with lethal cancer was similar for regular and decaffeinated coffee (each one cup per day increment: RR = 0.94 ... for regular coffee and RR = 0.91 ... for decaffeinated coffee ..."
"We observed a strong inverse association between coffee consumption and risk of lethal prostate cancer."
This study suggests that coffee consumption perhaps becomes more important after PCa initiation.
-Patrick
[1] ncbi.nlm.nih.gov/pubmed/284...
Int J Cancer. 2017 Apr 24. doi: 10.1002/ijc.30720. [Epub ahead of print]
Reduction by coffee consumption of prostate cancer risk: Evidence from the Moli-sani cohort and cellular models.
Pounis G1, Tabolacci C2, Costanzo S1, Cordella M2, Bonaccio M1, Rago L3, D'Arcangelo D4, Filippo Di Castelnuovo A1, de Gaetano G1, Donati MB1, Iacoviello L1,5, Facchiano F2; Moli-sani study investigators6.
Author information
Abstract
Meta-analytic data on the effect of coffee in prostate cancer risk are controversial. Caffeine as a bioactive compound of coffee has not yet been studied in deep in vitro. Our study aimed at evaluating in a population cohort the effect of Italian-style coffee consumption on prostate cancer risk and at investigating in vitro the potential antiproliferative and antimetastatic activity of caffeine on prostate cancer cell lines. 6,989 men of the Moli-sani cohort aged ≥50 years were followed for a mean of 4.24 ± 1.35 years and 100 new prostate cancer cases were identified. The European Prospective Investigation into Cancer and Nutrition-Food Frequency Questionnaire was used for the dietary assessment and the evaluation of Italian-style coffee consumption. Two human prostate cancer cell lines, PC-3 and DU145, were tested with increasing concentrations of caffeine, and their proliferative/metastatic features were evaluated. The newly diagnosed prostate cancer participants presented lower coffee consumption (60.1 ± 51.3 g/day) compared to the disease-free population (74.0 ± 51.7 g/day) (p < 0.05). Multiadjusted analysis showed that the subjects at highest consumption (>3 cups/day) had 53% lower prostate cancer risk as compared to participants at the lowest consumption (0-2 cups/day) (p = 0.02). Both human prostate cancer cell lines treated with caffeine showed a significant reduction in their proliferative and metastatic behaviors (p < 0.05). In conclusion, reduction by Italian-style coffee consumption of prostate cancer risk (>3 cups/day) was observed in epidemiological level. Caffeine appeared to exert both antiproliferative and antimetastatic activity on two prostate cancer cell lines, thus providing a cellular confirmation for the cohort study results.
© 2017 UICC.
KEYWORDS:
antineoplastic activity; caffeine; coffee; prostate cancer
PMID: 28436066 DOI: 10.1002/ijc.30720